129 related articles for article (PubMed ID: 22877883)
1. [Cytogenomic studies of hydatiform moles and gestational choriocarcinoma].
Poaty H; Coullin P; Leguern E; Dessen P; Valent A; Afoutou JM; Peko JF; Candelier JJ; Gombé-Mbalawa C; Picard JY; Bernheim A
Bull Cancer; 2012 Sep; 99(9):827-43. PubMed ID: 22877883
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide high-resolution aCGH analysis of gestational choriocarcinomas.
Poaty H; Coullin P; Peko JF; Dessen P; Diatta AL; Valent A; Leguern E; Prévot S; Gombé-Mbalawa C; Candelier JJ; Picard JY; Bernheim A
PLoS One; 2012; 7(1):e29426. PubMed ID: 22253721
[TBL] [Abstract][Full Text] [Related]
3. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
Wake N; Arima T; Matsuda T
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
[TBL] [Abstract][Full Text] [Related]
4. [Changes in gene expression profiles of hydatidiform mole and choriocarcinoma as compared with trophoblast hyperplasia].
Cui JQ; Shi YF; Zhou HJ; Li JQ
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):727-31. PubMed ID: 15733390
[TBL] [Abstract][Full Text] [Related]
5. Choriocarcinoma in Women: Analysis of a Case Series With Genotyping.
Savage J; Adams E; Veras E; Murphy KM; Ronnett BM
Am J Surg Pathol; 2017 Dec; 41(12):1593-1606. PubMed ID: 28877059
[TBL] [Abstract][Full Text] [Related]
6. Chromosome and cellular origin of choriocarcinoma.
Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
[TBL] [Abstract][Full Text] [Related]
7. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
9. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
[TBL] [Abstract][Full Text] [Related]
10. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
11. miR-21 Is Overexpressed in Hydatidiform Mole Tissues and Promotes Proliferation, Migration, and Invasion in Choriocarcinoma Cells.
Wang YX; Zhao JR; Xu YY; Wu WB; Zhang HJ
Int J Gynecol Cancer; 2017 Feb; 27(2):364-374. PubMed ID: 27922982
[TBL] [Abstract][Full Text] [Related]
12. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
13. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
14. Sister chromatid exchange and chromosome breakage in complete hydatidiform moles.
Becker RA; Surti U; Wenger SL
Cancer Genet Cytogenet; 1992 Aug; 62(1):53-7. PubMed ID: 1521235
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
16. FIGO Stage III Metastatic Gestational Choriocarcinoma Developed From an Antecedent Partial Hydatidiform Molar Pregnancy Bearing a Numerical Chromosomal Aberration 68, XX: A Case Report and Literature Review.
Ma N; Litkouhi B; Mannion CM
Int J Gynecol Pathol; 2016 Mar; 35(2):162-6. PubMed ID: 26352546
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetics of trophoblasts from complete hydatidiform moles.
Habibian R; Surti U
Cancer Genet Cytogenet; 1987 Dec; 29(2):271-87. PubMed ID: 3677047
[TBL] [Abstract][Full Text] [Related]
18. [HLA and molar pregnancies (triploidies, hydatidiform moles and choriocarcinoma). Etiological and epidemiological study].
Couillin P; Ravisé N; Afoutou JM; Chaïbi R; Azoulay M; Hors J; Oury JF; Boué J; Boué A
Ann Genet; 1987; 30(4):197-208. PubMed ID: 3501264
[TBL] [Abstract][Full Text] [Related]
19. Using short tandem repeat analysis for choriocarcinoma diagnosis: a case series.
Zhang X; Yan K; Chen J; Xie X
Diagn Pathol; 2019 Aug; 14(1):93. PubMed ID: 31421690
[TBL] [Abstract][Full Text] [Related]
20. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
Wake N
Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
